Long-term serial assessment of neointima by coronary angioscopy and NIRS-IVUS following treatment of PCSK9 inhibitor (DESNOTE-R study)

Long-term serial assessment of neointima by coronary angioscopy and NIRS-IVUS following treatment of PCSK9 inhibitor (DESNOTE-R study) - DESNOTE-Revive (DESNOTE-R)

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000037279

Enrollment

100

Registered

2019-07-05

Start date

2019-04-03

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

coronary heart disease

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients in the DESNOTE study in whom LDL cholesterol is insufficiently controlled.

Exclusion criteria

Exclusion criteria: Patients who is thought to be inappropriate for PCSK9 inhibitor

Design outcomes

Primary

Measure	Time frame
Very late stent failure defined as 1) cardiac death, 2) myocardial infarction or unstable angina due to the target stent, or 3) target lesion revascularization. Cardiac death was defined as the death without known non-cardiac cause.	—

Countries

Japan

Contacts

Public ContactYohei Sotomi

Osaka Police Hospital Cardiovascular Division

sotomiyohei@gmail.com06-6771-6051

Outcome results